Teva Homepage Print this page Site Map
About TevaInvestor RelationsTeva Worldwide

Press Releases

Jerusalem, Israel, May 12, 2008
Teva To Present At The Bank Of America Health Care Conference

Jerusalem, Israel, May 6, 2008
Teva Reports First Quarter 2008 Results

Jerusalem, Israel, April 30, 2008
Teva Announces Global In-Market First Quarter Sales Of Copaxone® Increased 35% To $542 Million

Jerusalem, Israel, April 28, 2008
Teva Announces Approval Of Generic Flolan® For Injection

Jerusalem, Israel, April 23, 2008
Teva To Report First Quarter 2008 Financial

Jerusalem, April 17, 2008
Teva Announces Tentative Approval Of Generic Evista® Tablets

Jerusalem, April 17, 2008
Teva Announces Tentative Approval Of Generic Maxalt® Tablets

Jerusalem, April 16, 2008
Early Treatment With Copaxone® Significantly Delayed Progression To Clinically Definite Multiple Sclerosis

Jerusalem, Israel, April 11, 2008
Teva Announces Brussels Court Decision To Revoke MSD's European Patent On Fosamax®

Jerusalem, Israel, April 11, 2008
Teva Receives Court Ruling Awarding Exclusivity For Generic Risperdal®

Jerusalem, Israel, April 10, 2008
Copaxone® Significantly Reduced Annual Relapse Rates And Stabilized Disease Progression In Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment

Jerusalem, Israel, March 31, 2008
Teva Provides Update On Generic Prevacid® Litigation

Jerusalem, Israel and Exeter, NH, March 31, 2008
Teva to Acquire Bentley Pharmaceuticals

Jerusalem, Israel, March 28, 2008
Teva Provides Update On Generic Aricept® Litigation

Jerusalem, Israel, March 25, 2008
Teva Reports 2007 Financials in XBRL Standard

Jerusalem, Israel, March 17, 2008
Teva to Present at the Lehman Brothers 11th Annual Global Healthcare Conference and at the Cowen and Company 28th Annual Healthcare Conference

Jerusalem, Israel, March 13, 2008
Teva Provides Update On Glatiramer Acetate 40mg For Amyotrophic Lateral Sclerosis (ALS)

Jerusalem, Israel, March 12, 2008
Teva To Present At The Bear Stearns 10th Annual London Healthcare Conference

Jerusalem, Israel, March 5, 2008
Teva Provides Update On Generic Risperdal®

Jerusalem, Israel, February 29, 2008
Teva Provides Update On Generic Actonel® Litigation

Jerusalem, Israel, February 28, 2008
Teva Announces Approval Of Generic Camptosar®

Jerusalem, Israel, February 25, 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax®

Jerusalem, Israel, February 21, 2008
Teva's Developed G-CSF is the First Biosimilar to Receive a Positive Opinion from European Union Regulators

Jerusalem, Israel, February 21, 2008
Teva Presents Growth Strategy At Investor Day Company Provides Long Term Strategic Goals Teva Announces Closing Of Cogenesys Acquisition

Jerusalem, Israel, February 19, 2008
Teva Invites Public To Listen To Investor Day Webcast

Jerusalem, Israel, February 12, 2008
Teva Provides 2008 And 2009 Financial Outlook

Jerusalem, Israel, February 12, 2008
Teva Reports Fourth Quarter And Full Year 2007 Results

Jerusalem, Israel, February 6, 2008
Teva Announces Approval of Generic Fosamax® Tablets

Jerusalem, Israel, February 1, 2008
Teva Provides Update On Generic Protonix®

Jerusalem, Israel, January 31, 2008
Teva Announces Tentative Approval Of Generic Flomax® Capsules

Jerusalem, Israel, January 30, 2008
Teva Announces Wyeth Voids Standstill Agreement On Generic Protonix®

Jerusalem, Israel, January 29, 2008
Teva To Present At The 2008 Wachovia Healthcare Conference

Jerusalem, Israel, January 29, 2008
Teva To Report Fourth Quarter And Full Year 2007 Financial Results On February 12, 2008

Jerusalem, Israel, January 23, 2008
Teva Announces Tentative Approval Of Generic Prevacid® Delayed-Release Capsules

Jerusalem, Israel, January 22, 2008
Teva Announces Extension To Standstill Agreement On Generic Protonix®

Jerusalem, Israel, January 22, 2008
Teva to Acquire CoGenesys Acquisition Will Bolster Teva's Biotechnology Capabilities

Jerusalem, Israel, January 17, 2008
Teva Announces Approval Of Pravastatin Sodium Tablets, 80 Mg

North Wales, Pa. and Atlanta, January 16, 2008
Teva Specialty Pharmaceuticals And UCB Announce U.S. Respiratory Collaboration Agreement

Jerusalem, Israel, January 14, 2008
Teva Announces Tentative Approval Of Generic Aricept® Tablets

Jerusalem, Israel, January 14, 2008
Teva to Explore Strategic Alternatives for its Animal Health Business

Jerusalem, Israel, January 10, 2008
Teva Announces Departure Of North American CEO , William S. Marth To Become Ceo Of Teva North America

Jerusalem, Israel, January 3, 2008
Teva To Present At The Morgan Stanley Pharmaceutical CEO's Unplugged Conference And At The 26th Annual Jpmorgan Healthcare Conference

Jerusalem, Israel, January 3, 2008
Teva Announces Approval Of Generic Kytril® Injection And Tablets

Jerusalem, Israel, January 2, 2008
Teva Announces Approval Of Generic Duoneb®






Archive:  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999